HRID 1669594生成物として
Panobinostat Lactate
960055-56-5CC(O)C(=O)O.Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1XVDWNSFFSMWXJJ-ASTDGNLGSA-NPanobinostat lactate is a lactate salt having panobinostat(1+) as the counterion. A histone deacetylase inhibitor used in combination with bortezomib and dexamethasone for the treatment of multiple myeloma. It has a role as an antineoplastic agent, an angiogenesis modulating agent and an EC 3.5.1.98 (histone deacetylase) inhibitor. It is a lactate salt and an organoammonium salt. It contains a panobinostat(1+).
FDA approved drugs -> Active ingredient
EMA approved medicines: Human medicine
FDA approved drugs -> Active ingredient
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Drug Induced Liver Injury Rank (DILIrank 2.0)
Panobinostat lactate
Ambiguous-DILI-concern
3
Warnings & precautions
DOI:10.1016/j.drudis.2016.02.015
960055-56-5DTXSID401026247CHEMBL3545368CHEBI:85991